COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

The incidence of COVID-19 infection in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is similar to that in the general population, but the mortality rate is much higher. COVID-19 vaccination is strongly recommended for PAH/CTEPH patient...

Full description

Bibliographic Details
Main Authors: Maria Wieteska-Miłek, Sebastian Szmit, Michał Florczyk, Beata Kuśmierczyk-Droszcz, Robert Ryczek, Marcin Kurzyna
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
pulmonary arterial hypertension
chronic thromboembolic pulmonary hypertension
COVID-19 vaccine
vaccination
post-vaccination symptoms
safety
Online Access:https://www.mdpi.com/2076-393X/9/12/1395

Internet

https://www.mdpi.com/2076-393X/9/12/1395

Similar Items